CEO Total Pay
$9.1M
FY2021 Summary Compensation, above median
APLS FY2021 SEC EDGAR DEF 14A
Apellis Pharmaceuticals, Inc. CEO pay ratio
The CEO earned $9.1M in FY2021 against median worker pay of $321,867 · Chemicals & Pharmaceuticals.
- State
- DE
- Filing date
- 2022-04-20
- Industry
- Chemicals & Pharmaceuticals
- Fiscal year
- FY2021
Data updated August 2026
Subscribe to Apellis Pharmaceuticals, Inc. CEO pay filing updates (RSS)
CEO-to-worker pay ratio
3:1
Below Average (Scale: 0–1000:1)
CEO pay
$9.1M
Median worker
$321,867
Latest filing FY2021. This company's newest DEF 14A on file is for FY2021, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.
Answer first
Apellis Pharmaceuticals, Inc. reported a 3:1 CEO-to-worker pay ratio in FY2021 - at or below the Chemicals & Pharmaceuticals median of 42:1 across 168 filers.
Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.
- Pay ratio
- 3:1
- FY2021 disclosed
- CEO total
- $9.1M
- Summary Compensation Table total
- Median worker
- $321,867
- Dodd-Frank median employee
Ratio bands among Chemicals & Pharmaceuticals peers
Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.
CEO Compensation Breakdown, FY2021
A component-level pay breakdown is not reported in Apellis Pharmaceuticals, Inc.'s structured SEC pay-ratio disclosure. See our methodology →
Industry Comparison - Chemicals & Pharmaceuticals
This Company's Ratio
3:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$9.1M
Companies in Industry
168
vs. Industry Median
Below
Apellis Pharmaceuticals, Inc.: near-parity Item 402(u) ratio
Apellis Pharmaceuticals, Inc. stamps FLOOR · ELITE-MED at 3:1 against $321,867 median worker pay in FY2021. the CEO earned 3× the median employee ($321,867) in FY2021.
At $321,867 median worker pay, the FLOOR stamp is near pay-parity territory under HEAVY CEO total.
Pay Ratio
3:1
Below typical
What FY2021 shows for Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. stamps FLOOR · ELITE-MED at 3:1 against $321,867 median worker pay in FY2021. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Apellis Pharmaceuticals, Inc.'s $9.1M CEO total is above the $7.9M industry median CEO pay.
Apellis Pharmaceuticals, Inc. stamps FLOOR · HEAVY · ELITE-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.
Key Data, FY2021
- Total Compensation
- $9.1M
- Median Employee Pay
- $321,867
- Pay Ratio
- 3:1
- Filing Date
- 2022-04-20
Company Info
- Ticker
- APLS
- CIK
- 1492422
- Industry
- Chemicals & Pharmaceuticals
- SIC Code
- 2834
- State
- DE
SEC EDGAR DEF 14A for CIK 1492422, FY2021. Informational only, not investment advice. Verify on EDGAR.
Read our methodology - how this data is sourced, computed, and verified. Apellis Pharmaceuticals, Inc. stamps FLOOR · ELITE-MED at 3:1 against $321,867 median worker pay in FY2021.
Read with Apellis Pharmaceuticals, Inc.
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · HEAVY · ELITE-MED.
Piper Sandler Companies · HEAVY
ABS(ceo_total_comp) peer at $9.1M (Δ $16K heavier vs Apellis Pharmaceuticals, Inc.); MODEST · ELITE-MED vs this page's FLOOR · HEAVY · ELITE-MED.
Sumisho Air Lease Corp · HEAVY
ABS(ceo_total_comp) peer at $9.1M (Δ $27K heavier vs Apellis Pharmaceuticals, Inc.); MODEST · ELITE-MED vs this page's FLOOR · HEAVY · ELITE-MED.
Appian Corp · HEAVY
ABS(ceo_total_comp) peer at $9.2M (Δ $36K heavier vs Apellis Pharmaceuticals, Inc.); MODEST · ELITE-MED vs this page's FLOOR · HEAVY · ELITE-MED.
Imax Corp · HEAVY
ABS(ceo_total_comp) peer at $9.1M (Δ $41K lighter vs Apellis Pharmaceuticals, Inc.); MID · HIGH-MED vs this page's FLOOR · HEAVY · ELITE-MED.
Chemicals & Pharmaceuticals benchmark
Apellis Pharmaceuticals, Inc. stamps FLOOR · HEAVY · ELITE-MED inside SIC 28 - open the industry median board after the ABS peers.
Pay-ratio rankings · FLOOR
See where FLOOR · HEAVY packages sit on the national leaderboard after reading Apellis Pharmaceuticals, Inc..
Ratio primer · FLOOR
Apellis Pharmaceuticals, Inc.'s FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Apellis Pharmaceuticals, Inc. (CIK 1492422), FY2021. See our methodology. Aggregated by PlainCEOPay as of August 2026.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.